摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

Aethyl-decyl-sulfoxid | 24475-76-1

中文名称
——
中文别名
——
英文名称
Aethyl-decyl-sulfoxid
英文别名
1-Ethylsulfinyldecane
Aethyl-decyl-sulfoxid化学式
CAS
24475-76-1
化学式
C12H26OS
mdl
——
分子量
218.404
InChiKey
SXWXXYCJTDGKAE-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.1
  • 重原子数:
    14
  • 可旋转键数:
    10
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    1.0
  • 拓扑面积:
    36.3
  • 氢给体数:
    0
  • 氢受体数:
    2

文献信息

  • Transdermal treatment with mast cell degranulating agents for drug-induced hypersensitivity
    申请人:BRISTOL-MYERS SQUIBB COMPANY
    公开号:EP0612525A1
    公开(公告)日:1994-08-31
    Methods and compositions for inhibiting or preventing the skin irritating or sensitizing effects of a skin irritating or sensitizing component of a dermal or transdermal drug delivery system are disclosed. The composition comprises a mast cell degranulating agent which is capable of inducing a state of immunological tolerance to the skin sensitizing agent by delivery prior to, or at the onset of transdermal drug delivery. Such an agent, preferably cis-urocanic acid or an analogue or metabolite thereof, can be administered before, during or after each transdermal drug delivery to achieve immune tolerance countersensitization. Alternatively, the agent can be used to induce countersensitization. The agent is preferably capable of permeating the epidermis and is administered transdermally. Novel methods and compositions comprising cis-urocanic acid or an analogue or metabolite thereof to obtain anti-inflammatory effects are also disclosed.
    本发明公开了用于抑制或预防皮肤或透皮给药系统中皮肤刺激性或致敏成分的皮肤刺激或致敏效应的方法和组合物。该组合物包含一种肥大细胞脱颗粒剂,它能够在透皮给药之前或开始时通过给药诱导对皮肤致敏剂的免疫耐受状态。可以在每次透皮给药之前、期间或之后给药这种药剂,最好是顺式尿囊酸或其类似物或代谢物,以达到免疫耐受反敏的目的。或者,也可以使用该药剂来诱导反敏。药剂最好能渗透表皮,并经皮肤给药。此外,还公开了包含顺式尿囊酸或其类似物或代谢物以获得抗炎效果的新方法和组合物。
  • Transdermal acrylic multipolymer drug delivery system
    申请人:NOVEN PHARMACEUTICALS, INC.
    公开号:EP0379045B1
    公开(公告)日:1995-05-10
  • SOLUBILITY PARAMETER BASED DRUG DELIVERY SYSTEM AND METHOD FOR ALTERING DRUG SATURATION CONCENTRATION
    申请人:NOVEN PHARMACEUTICALS, INC.
    公开号:EP0591432A1
    公开(公告)日:1994-04-13
  • EP0591432A4
    申请人:——
    公开号:EP0591432A4
    公开(公告)日:1995-05-17
  • METHOD AND APPARATUS FOR DIAGNOSING ERECTILE DYSFUNCTION
    申请人:Vivus, Inc.
    公开号:EP0754006A1
    公开(公告)日:1997-01-22
查看更多